Skip to main content

Advertisement

Log in

Appropriateness of timing of drug administration in electronic prescriptions

  • Research Article
  • Published:
Pharmacy World & Science Aims and scope Submit manuscript

Abstract

Introduction For a small number of drugs circadian variability has been shown to modify efficacy, safety, or pharmacokinetics. Objective of the study We aimed to develop a database containing optimum timing of drug administration and to test how well such information is considered in daily practice. Setting University hospital providing primary and tertiary care. Methods We included data of randomised controlled trials collected from Embase and Medline studying the impact of the timing of drug administration on pharmacodynamics, pharmacokinetics, and adverse events. Data were analysed and weighed according to an algorithm considering trial design and assessed endpoints. Each branch of the algorithm led to a specific recommendation as to the time of the day the drug should be administered. A second algorithm was used to establish a recommendation if studies differed in their conclusion. Subsequently we retrospectively analysed the dosing time in consecutive electronic prescriptions issued at our institution in 2007. Results For 30 active compounds randomised controlled trials were published assessing optimum timing of their administration. In 33% of them timing had no impact on clinical endpoints while the administration at a certain time of the day significantly improved the outcome of another 64% no clear statement was made for one drug (ketoprofen). We then analysed 478864 electronic prescriptions. Two percent of them contained drugs with known circadian variability. Only in 14% the suggested time was considered with a range between 0% for telmisartan (bedtime administration) and 85% for perindopril (morning administration). Conclusion Thus far, dedicated studies on circadian responsiveness to drugs are sparse and for the few drugs with unequivocal evidence this information is only rarely considered in daily practice. Integration of circadian dosing information into a clinical decision support system linked to electronic prescribing may be one promising way to make this information widely accessible.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Smolensky MH, Portaluppi F. Chronopharmacology and chronotherapy of cardiovascular medications relevance to prevention and treatment of coronary heart disease. Am Heart J. 1999;137:14–24.

    Article  Google Scholar 

  2. Lemmer B. The clinical relevance of chronopharmacology in therapeutics. Pharmacol Res. 1996;33:107–15.

    Article  CAS  PubMed  Google Scholar 

  3. Goo RH, Moore JG, Greenberg E, Alazraki NP. Circadian variation in gastric emptying of meals in humans. Gastroenterology. 1987;93:515–8.

    CAS  PubMed  Google Scholar 

  4. Lemmer B, Nold G. Circadian changes in estimated hepatic blood flow in healthy subjects. Br J Clin Pharmacol. 1991;32:627–9.

    CAS  PubMed  Google Scholar 

  5. Shaw GL, Falk RT, Caporaso NE, Issaq HJ, Kase RG, Fox SD, et al. Effect of diurnal variation on debrisoquine metabolic phenotyping. J Natl Cancer Inst. 1990;82:1573–5.

    Article  CAS  PubMed  Google Scholar 

  6. Bleyzac N, Allard-Latour B, Laffont A, Mouret J, Jelliffe R, Maire P. Diurnal changes in the pharmacokinetic behavior of amikacin. Ther Drug Monit. 2000;22:307–12.

    Article  CAS  PubMed  Google Scholar 

  7. Kitahara Y, Saito F, Akao M, Fujita H, Takahashi A, Taguchi H, et al. Effect of morning and bedtime dosing with cilnidipine on blood pressure, heart rate, and sympathetic nervous. J Cardiovasc Pharmacol. 2004;43:68–73.

    Article  CAS  PubMed  Google Scholar 

  8. Hermida RC, Calvo C, Ayala DE, López JE, Rodríguez M, Chayán L, et al. Dose- and administration time-dependent effects of nifedipine gits on ambulatory blood pressure in hypertensive subjects. Chronobiol Int. 2007;24:471–93.

    Article  CAS  PubMed  Google Scholar 

  9. White WB, Mansoor GA, Pickering TG, Vidt DG, Hutchinson HG, Johnson RB, et al. Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate. Am J Hypertens. 1999;12:806–14.

    Article  CAS  PubMed  Google Scholar 

  10. Usher RW, Beasley CM Jr, Bosomworth JC. Efficacy and safety of morning versus evening fluoxetine administration. J Clin Psychiatry. 1991;52:134–6.

    CAS  PubMed  Google Scholar 

  11. Vashi V, Chung M, Dias N, Phillips K. Effect of time of administration on the pharmacokinetics and tolerance of doxazosin in healthy male volunteers. J Clin Pharmacol. 1996;36:325–31.

    CAS  PubMed  Google Scholar 

  12. Kirby RS, Chapple CR, Sethia K, Flannigan M, Milroy EJ, Abrams P. Morning vs evening dosing with doxazosin in benign prostatic hyperplasia: efficacy and safety. Prostate Cancer Prostatic Dis. 1998;1:163–71.

    Article  CAS  PubMed  Google Scholar 

  13. Khasawneh SM, Affarah HB. Morning versus evening dose: a comparison of three H2-receptor blockers in duodenal ulcer healing. Am J Gastroenterol. 1992;87:1180–2.

    CAS  PubMed  Google Scholar 

  14. Hongo M, Ohara S, Hirasawa Y, Abe S, Asaki S, Toyota T. Effect of lansoprazole on intragastric pH. Comparison between morning and evening dosing. Dig Dis Sci. 1992;37:882–90.

    Article  CAS  PubMed  Google Scholar 

  15. Scharnagl H, Vogel M, Abletshauser C, Freisinger F, Stojakovic T, März W. Efficacy and safety of fluvastatin-extended release in hypercholesterolemic patients: morning administration is equivalent to evening administration. Cardiology. 2006;106:241–8.

    Article  CAS  PubMed  Google Scholar 

  16. Fogari R, Malacco E, Tettamanti F, Gnemmi AE, Milani M. Evening vs. morning isradipine sustained release in essential hypertension: a double-blind study with 24 h ambulatory monitoring. Br J Clin Pharmacol. 1993;35:51–4.

    CAS  PubMed  Google Scholar 

  17. Kuroda T, Kario K, Hoshide S, Hashimoto T, Nomura Y, Saito Y, et al. Effects of bedtime vs. morning administration of the long-acting lipophilic angiotensin-converting enzyme inhibitor trandolapril on morning blood pressure in hypertensive patients. Hypertens Res. 2004;27:15–20.

    Article  CAS  PubMed  Google Scholar 

  18. Postma DS, Sevette C, Martinat Y, Schlösser N, Aumann J, Kafé H. Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening. Eur Respir J. 2001;17:1083–8.

    Article  CAS  PubMed  Google Scholar 

  19. Deedwania PC, Pool PE, Thadani U, Eff J. Effect of morning versus evening dosing of diltiazem on myocardial ischemia detected by ambulatory electrocardiographic monitoring in chronic stable angina pectoris. Dilacor XR Ambulatory Ischemia Study Group. Am J Cardiol. 1997;80:421–5.

    Article  CAS  PubMed  Google Scholar 

  20. Glass-Marmor L, Paperna T, Galboiz Y, Miller A. Immunomodulation by chronobiologically-based glucocorticoids treatment for multiple sclerosis relapses. J Neuroimmunol. 2009;210:124–7.

    Article  CAS  PubMed  Google Scholar 

  21. Lund TM, Torsvik H, Falch D, Christophersen B, Skårdal R, Gullestad L. Effect of morning versus evening intake of simvastatin on the serum cholesterol level in patients with coronary artery disease. Am J Cardiol. 2002;90:784–6.

    Article  CAS  PubMed  Google Scholar 

  22. Wallace A, Chinn D, Rubin G. Taking simvastatin in the morning compared with in the evening: randomised controlled trial. BMJ. 2003;327:788.

    Article  PubMed  Google Scholar 

  23. Pehlivanov ND, Olyaee M, Sarosiek I, McCallum RW. Comparison of morning and evening administration of rabeprazole for gastro-oesophageal reflux and nocturnal gastric acid breakthrough in patients with reflux disease: a double-blind, cross-over study. Aliment Pharmacol Ther. 2003;18:883–90.

    Article  CAS  PubMed  Google Scholar 

  24. Kerr DJ, Lewis C, O’Neil B, Lawson N, Blackie RG, Newell DR, et al. The myelotoxicity of carboplatin is influenced by the time of its administration. Hematol Oncol. 1990;8:59–63.

    Article  CAS  PubMed  Google Scholar 

  25. Palatini P, Racioppa A, Raule G, Zaninotto M, Penzo M, Pessina AC. Effect of timing of administration on the plasma ACE inhibitory activity and the antihypertensive effect of quinapril. Clin Pharmacol Ther. 1992;52:378–83.

    CAS  PubMed  Google Scholar 

  26. Levi F, Le Louarn C, Reinberg A. Timing optimizes sustained-release indomethacin treatment of osteoarthritis. Clin Pharmacol Ther. 1985;37:77–84.

    CAS  PubMed  Google Scholar 

  27. Ozaydin M, Dede O, Dogan A, Aslan SM, Altinbas A, Ozturk M, et al. Effects of morning versus evening intake of atorvastatin on major cardiac event and restenosis rates in patients undergoing first elective percutaneous coronary intervention. Am J Cardiol. 2006;97:44–7.

    Article  CAS  PubMed  Google Scholar 

  28. Cilla DD Jr, Gibson DM, Whitfield LR, Sedman AJ. Pharmacodynamic effects and pharmacokinetics of atorvastatin after administration to normocholesterolemic subjects in the morning and evening. J Clin Pharmacol. 1996;36:604–9.

    CAS  PubMed  Google Scholar 

  29. Portaluppi F, Vergnani L, Manfredini R, degli Uberti EC, Fersini C. Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure. Am J Hypertens. 1995;8:719–26.

    Article  CAS  PubMed  Google Scholar 

  30. Busse WW, Bush RK. Comparison of morning and evening dosing with a 24-hour sustained-release theophylline, Uniphyl, for nocturnal asthma. Am J Med. 1985;79:62–6.

    Article  CAS  PubMed  Google Scholar 

  31. Su YM, Cheng TP, Yeh TW, Wen CY, Wang DI. Influence of morning or evening administration on absorption of theophylline. Zhonghua Yi Xue Za Zhi. 2000;63:113–8.

    CAS  PubMed  Google Scholar 

  32. Nold G, Strobel G, Lemmer B. Morning versus evening amlodipine treatment: effect on circadian blood pressure profile in essential hypertensive patients. Blood Press Monit. 1998;3:17–25.

    PubMed  Google Scholar 

  33. Qiu YG, Chen JZ, Zhu JH, Yao XY. Differential effects of morning or evening dosing of amlodipine on circadian blood pressure and heart rate. Cardiovasc Drugs Ther. 2003;17:335–41.

    Article  CAS  PubMed  Google Scholar 

  34. Kuwajima I, Suzuki Y, Shimosawa T, Kanemaru A, Hoshino S, Kuramoto K. Diminished nocturnal decline in blood pressure in elderly hypertensive patients with left ventricular hypertrophy. Am Heart J. 1992;123:1307–11.

    Article  CAS  PubMed  Google Scholar 

  35. Morgan T, Anderson A, Jones E. The effect on 24 h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night. J Hypertens. 1997;15:205–11.

    Article  CAS  PubMed  Google Scholar 

  36. Prichard PJ, Yeomans ND, Mihaly GW, Jones DB, Buckle PJ, Smallwood RA, et al. Omeprazole: a study of its inhibition of gastric pH and oral pharmacokinetics after morning or evening dosage. Gastroenterology. 1985;88:64–9.

    CAS  PubMed  Google Scholar 

  37. Müssig S, Witzel L, Lühmann R, Schneider A. Morning and evening administration of pantoprazole: a study to compare the effect on 24-hour intragastric pH. Eur J Gastroenterol Hepatol. 1997;9:599–602.

    PubMed  Google Scholar 

  38. Hermida RC, Ayala DE, Calvo C, López JE, Mojón A, Rodríguez M, et al. Differing administration time-dependent effects of aspirin on blood pressure in dipper and non-dipper hypertensives. Hypertension. 2005;46:1060–8.

    Article  CAS  PubMed  Google Scholar 

  39. Moore JG, Goo RH. Day and night aspirin-induced gastric mucosal damage and protection by ranitidine in man. Chronobiol Int. 1987;4:111–6.

    Article  CAS  PubMed  Google Scholar 

  40. Hermida RC, Calvo C, Ayala DE, Domínguez MJ, Covelo M, Fernández JR, et al. Administration time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects. Hypertension. 2003;42:283–90.

    Article  CAS  PubMed  Google Scholar 

  41. Hermida RC, Calvo C, Ayala DE, Fernández JR, Covelo M, Mojón A, et al. Treatment of non-dipper hypertension with bedtime administration of valsartan. J Hypertens. 2005;23:1913–22.

    Article  CAS  PubMed  Google Scholar 

  42. Hermida RC, Calvo C, Ayala DE, Mojón A, Rodríguez M, Chayán L, et al. Administration time-dependent effects of valsartan on ambulatory blood pressure in elderly hypertensive subjects. Chronobiol Int. 2005;22:755–76.

    Article  CAS  PubMed  Google Scholar 

  43. Hermida RC, Ayala DE, Fernández JR, Calvo C. Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension. Hypertension. 2007;50:715–22.

    Article  CAS  PubMed  Google Scholar 

  44. Hermida RC, Ayala DE, Chayan L, Mojon A, Fernandez JR. Administration-time-dependent effects of olmesartan on the ambulatory blood pressure of essential hypertension patients. Chronobiol Int. 2009;26:61–79.

    Article  CAS  PubMed  Google Scholar 

  45. Myburgh DP, Verho M, Botes JH, Erasmus TP, Luus HG. 24-Hour blood pressure control with ramipril: comparison of once-daily morning and evening administration. Current Ther Res. 1995;56:1298–306.

    Article  CAS  Google Scholar 

  46. Hermida RC, Ayala DE. Chronotherapy with the angiotensin-converting enzyme inhibitor ramipril in essential hypertension: improved blood pressure control with bedtime dosing. Hypertension. 2009;54:40–6.

    Article  CAS  PubMed  Google Scholar 

  47. Calvo C, Hermida RC, Ayala DE, López JE, Rodríguez M, Chayán L, et al. Chronotherapy with torasemide in hypertensive patients: increased efficacy and therapeutic coverage with bedtime administration. Med Clin. 2006;127:721–9.

    Article  Google Scholar 

  48. Reinberg A, Gervais P, Chaussade M, Fraboulet G, Duburque B. Circadian changes in effectiveness of corticosteroids in eight patients with allergic asthma. J Allergy Clin Immunol. 1983;71:425–33.

    Article  CAS  PubMed  Google Scholar 

  49. Vinje O, Fagertun HE, Laerum E, Lund H, Larsen S. Ketoprofen controlled release (CR) in the treatment of osteoarthrosis; a double blind, randomized multicentre study of single morning versus evening dose. Norwegian Study Group of General Practitioners. Scand J Prim Health Care. 1993;11:91–7.

    Article  CAS  PubMed  Google Scholar 

  50. Perpoint B, Mismetti P, Simitsidis S, Hocquart J, Rambaud C, Buchmuller A, et al. Dosing time optimizes sustained-release ketoprofen treatment of osteoarthritis. Chronobiol Int. 1994;11:119–25.

    Article  CAS  PubMed  Google Scholar 

  51. Poondru S, Devaraj R, Boinpally RR, Yamasani MR. Chronopharmacokinetics of sumatriptan in healthy human subjects. J Pharm Pharmacol. 2000;52:1085–90.

    Article  CAS  PubMed  Google Scholar 

  52. Kesselheim AS, Misono AS, Lee JL, Stedman MR, Brookhart MA, Choudhry NK, et al. Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA. 2008;300:2514–26.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This study was supported by the University of Heidelberg. Arwa Hassan’s work was funded by an unrestricted educational grant from Syria.

Conflict of Interest

The authors have no conflicts of interest to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Walter E. Haefeli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hassan, A., Haefeli, W.E. Appropriateness of timing of drug administration in electronic prescriptions. Pharm World Sci 32, 162–171 (2010). https://doi.org/10.1007/s11096-009-9362-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-009-9362-4

Keywords

Navigation